Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?

Documenti analoghi

• Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
  di: Mukhtyar, C, et al.
  Pubblicazione: (2006)
• Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
  di: Mukhtyar, C, et al.
  Pubblicazione: (2008)
• Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
  di: Saket Jha, et al.
  Pubblicazione: (2019-01-01)
• Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
  di: Zhi-Ying Li, et al.
  Pubblicazione: (2020-08-01)
• A Case of Postcoronavirus Disease 2019 Antineutrophil Cytoplasmic Antibody-associated Vasculitis Successfully Treated with Rituximab
  di: Mahmoud M. Mohamed, et al.
  Pubblicazione: (2023-07-01)